Rajnish Wellness Ltd

AI
Rajnish Wellness Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Rajnish Wellness Ltd

₹ 0.37 0.00%
16 Oct 10:42 a.m.
rajnishwellness.com BSE: 541601
About

Incorporated in 2015, Rajnish Wellness Ltd manufactures and sells various ayurvedic medicinal products.[1]

Key Points

Business Overview:[1]
RWL is currently engaged in the business of selling various products in the categories ranging from the pharmaceutical products,
consumer durables to ayurvedic personal care products. Its focus area is pharmaceutical, energy revitalization, ayurvedic ethical medicines, personal care products, medicinal sexual enhancement products which are easily
available across the medical counters.

Website BSE
  • Market Cap ₹ 37.6 Cr.
  • Current Price ₹ 0.37
  • High / Low ₹ 0.90 / 0.34
  • Stock P/E
  • Book Value ₹ 1.01
  • Dividend Yield 0.00 %
  • ROCE -8.99 %
  • ROE -6.74 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.37 times its book value
  • Debtor days have improved from 137 to 49.7 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 9.16%
  • Company has a low return on equity of -1.95% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.08%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
8.51 18.51 21.62 26.98 16.30 17.42 9.06 5.77 4.56 12.00 23.24 101.95 31.01
8.48 18.47 21.33 26.44 16.29 16.94 8.92 6.38 4.39 12.22 24.61 108.79 30.96
Operating Profit 0.03 0.04 0.29 0.54 0.01 0.48 0.14 -0.61 0.17 -0.22 -1.37 -6.84 0.05
OPM % 0.35% 0.22% 1.34% 2.00% 0.06% 2.76% 1.55% -10.57% 3.73% -1.83% -5.90% -6.71% 0.16%
0.83 0.23 0.00 0.00 0.35 0.00 0.01 0.16 0.12 0.31 0.37 0.02 0.08
Interest 0.13 0.14 0.12 0.11 0.13 0.10 0.04 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01
Profit before tax 0.73 0.13 0.17 0.42 0.23 0.37 0.10 -0.46 0.29 0.09 -1.01 -6.83 0.12
Tax % 24.66% 23.08% 35.29% 30.95% 26.09% 24.32% 20.00% 0.00% 27.59% 22.22% -9.90% -31.19% 0.00%
0.55 0.10 0.10 0.28 0.17 0.28 0.07 -0.46 0.22 0.06 -0.91 -4.70 0.12
EPS in Rs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.00 0.00 0.00 -0.01 -0.05 0.00
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
25 28 42 14 13 26 26 77 49 142 168
24 24 35 14 17 27 27 75 49 151 177
Operating Profit 1 3 7 0 -3 -0 -1 2 0 -9 -8
OPM % 4.7% 12% 16% 1.0% -24% -0.7% -4.3% 2.6% 0.0% -6% -5.0%
0 1 0 0 4 1 2 0 1 1 1
Interest 0 1 1 1 0 0 0 1 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 1 4 6 -1 0 0 1 1 0 -8 -8
Tax % 33% 33% 28% -2% 18% 15% 27% 29% 25% -25%
1 2 4 -1 0 0 0 1 0 -6 -5
EPS in Rs 0.05 0.06 0.08 -0.01 0.00 0.01 0.00 0.01 0.00 -0.06 -0.06
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 60%
3 Years: 77%
TTM: 357%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -5036%
Stock Price CAGR
10 Years: %
5 Years: -29%
3 Years: -69%
1 Year: -56%
Return on Equity
10 Years: 1%
5 Years: -1%
3 Years: -2%
Last Year: -7%

Balance Sheet

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.05 3 5 5 5 11 77 77 77 102
Reserves 1 3 18 17 17 12 6 7 7 1
3 4 5 8 0 0 10 5 0 0
5 8 5 4 13 13 6 17 7 6
Total Liabilities 8 18 32 33 35 35 99 106 91 109
0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 3 8
8 18 32 33 35 35 99 106 88 101
Total Assets 8 18 32 33 35 35 99 106 91 109

Cash Flows

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-2 -3 -9 -7 0 -0 -62 2 -4 -9
-0 -0 -0 0 0 -0 -0 -0 9 -7
1 3 10 5 -0 1 62 -2 -5 25
Net Cash Flow -0 -0 1 -1 0 1 -1 -0 0 9
Free Cash Flow -2 -3 -9 -7 0 -0 -62 2 -4 -9
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -136% -90% -118% -4,650% -4% -32% 5,577% 105% -41,900% 94%

Ratios

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 59 182 164 318 460 224 287 160 201 50
Inventory Days 152 75 77 48 27 32 59 48 79 35
Days Payable 121 145 27 56 50 17 55 78 31 7
Cash Conversion Cycle 90 111 214 310 436 238 290 130 249 77
Working Capital Days 30 102 183 702 791 407 449 305 530 182
ROCE % 65% 37% 1% 2% 3% 1% 2% 1% -9%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Revenue Mix: Sexual Wellness/Branded Medicine
% of turnover

Log in to view insights

Please log in to see hidden values.

Login
Permanent Employees
employees
Revenue Mix: Branded Electronics
% of turnover
Number of States of Operation
states
Number of Retailers/Stores
stores
Number of Super Stockists
super stockists
Number of C&F Agents
C&F agents
Number of Dealers/Distributors Sold To
distributors

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
16.24% 16.24% 16.24% 16.24% 16.24% 7.41% 7.41% 7.41% 9.16% 9.16% 9.16% 9.16%
0.00% 0.00% 1.09% 1.20% 0.20% 0.00% 0.57% 0.57% 0.43% 0.43% 0.43% 0.43%
83.76% 83.77% 82.67% 82.56% 83.57% 92.59% 92.02% 92.03% 90.41% 90.41% 90.41% 90.41%
No. of Shareholders 20,00124,47545,01352,51797,3701,60,3111,66,5171,65,7971,65,6361,62,9551,60,2591,58,442

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Jun 2019
    Transcript
    AI Summary
    PPT
  • Mar 2019
    Transcript
    AI Summary
    PPT